Menu

Plan to Fight Zika with GM Mosquitoes Passes Popular Vote in Florida

The strategy to release mosquitoes that cannot spread the virus passed a county-level vote but faced opposition in one town. 

Nov 10, 2016
Ben Andrew Henry

CDC

An embattled plan to slow the spread of the Zika virus by releasing genetically modified (GM) mosquitoes passed a popular vote in one Florida county on Tuesday (November 8). A trial implementation of the strategy, which effectively cut down mosquito populations in early tests outside the state, was approved by the US Food and Drug Administration in August but faced vocal opposition by some Florida residents.

In nonbinding “straw polls,” 58 percent of residents of Monroe County approved the strategy. In a separate poll, however, residents of Key Haven, a town within Monroe County where the mosquitoes would be deployed, soundly rejected the proposal, with 65 percent voting against it.

The final decision will be left up to the Florida Keys Mosquito Control District Board, which will convene on November 19 to weigh public opinion, BBC News reported. Phil Goodman, chairman of the Florida Keys Mosquito Control District, told Wired that the plan will move forward in accordance with the county vote, but officials will seek a site other than Key Haven to implement the trial.

However, Derric Nimmo, who is leading the trial for the Oxitec, the British biotech company that designed the mosquitoes, told the BBC that “Key Haven was chosen about four years ago based on the fact that it’s surrounded by water and it’s an almost perfect scientific site where you have a control area where you don’t do any releases, an area where you can do releases, and a buffer zone in between.”

The trial would involve releasing male mosquitoes, which have been genetically modified to carry a gene that causes their offspring to die before reproducing, in one neighborhood of Key Haven. Since male mosquitoes do not bite, their release would not increase risk of Zika transmission. To the contrary, their introduction to mosquito populations in early testing reduced population sizes by around 90 percent, according to NPR’s Shots.

“We’ve had six years of releases, involving millions of male mosquitoes, and there have been no reports of any adverse effects,” Nimmo told the BBC. “It’s important we’re as transparent as possible . . . we’ve been trying to give people the facts and information so they can make an informed choice.”

Update (November 22): On November 19, the Mosquito Control District Board voted 3-2 in favor of the field trial, though they have yet to establish a new site to release mosquitoes, STAT News reported.

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

Horizon Discovery Group plc, a global leader in gene editing and gene modulation technologies, today announced the launch of its Myeloid DNA Reference Standard. The first-to-market large cell-line derived myeloid cancer reference standard designed enables faster, more reliable and more cost-effective assay validation, to support the market in bringing routine testing into practice.

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!